Actively Recruiting

Phase Not Applicable
FEMALE
NCT06480513

Cancer Of the BReast Asanas Study (COBRA)

Led by UMC Utrecht · Updated on 2026-05-06

140

Participants Needed

1

Research Sites

138 weeks

Total Duration

On this page

Sponsors

U

UMC Utrecht

Lead Sponsor

W

World Cancer Research Fund International

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rationale: Women with hormone-receptor positive breast cancer are usually prescribed endocrine therapy for a period of 5-10 years. This treatment reduces the risk of recurrence and improves overall survival in these women. Musculoskeletal complaints are a common (\~50%) negative consequence of endocrine treatment, which affects daily functioning and quality of life. These symptoms frequently result in early treatment discontinuation, which is associated with shorter disease-free survival. Musculoskeletal complaints are often pharmacologically treated with limited effect and accompanied by side-effects. Therefore, interventions to counteract musculoskeletal complaints are urgently needed in this population. A potential non-pharmacological option is yoga. In patients with osteoarthritis, there is emerging evidence that yoga is effective to reduce pain and stiffness and improve function. Yoga as treatment for musculoskeletal complaints that are associated with endocrine treatment is rarely investigated and mainly in small studies. Objective: The objective of the proposed study is to assess the effectiveness of a 4-month yoga program compared to a waiting list control group on musculoskeletal complaints in women with hormone-positive stage I-III breast cancer receiving endocrine treatment who report musculoskeletal complaints. Study design: The COBRA study is a randomized controlled trial with two study arms: a yoga- and a waiting list control group. Study population: For this study, 140 women with oestrogen-receptor positive stage I-III breast cancer on endocrine treatment (aromatase inhibitors or Tamoxifen; \>4 months) will be recruited. These women experience musculoskeletal complaints (\>3 months) which started or exacerbated after initiation of endocrine treatment. Furthermore, eligible women did not practice yoga in the last six months and are not planning to start yoga and are not highly physically active (i.e., \>150 minutes per week moderate-vigorous exercise). Intervention: The intervention consists of two one-hour sessions/week supervised yoga and once a week 30-minute yoga exercises at home. The 4-month yoga program will be an active form of yoga, such as Easy Vinyasa yoga, which is characterized by continuous slow movements linked with breathing. The waiting list control patients will be offered an online yoga program after the 4-month study period.

CONDITIONS

Official Title

Cancer Of the BReast Asanas Study (COBRA)

Who Can Participate

FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with oestrogen-receptor positive stage I-III breast cancer
  • Using aromatase inhibitors or Tamoxifen for more than 4 months and will continue for at least six months
  • Completed primary treatments (chemotherapy, radiotherapy, surgery) at least 12 weeks ago
  • Experiencing musculoskeletal complaints lasting over 3 months that started or worsened after starting endocrine therapy, with at least mild severity (pain score ≥ 3)
  • Stable on menopausal symptom medication for at least three months and antidepressants for at least three weeks, if applicable
  • Able to read, speak, and understand Dutch or English
Not Eligible

You will not qualify if you...

  • Physically active more than 150 minutes per week of moderate-to-vigorous or leisure and sports activities
  • Practiced yoga regularly in the last 6 months or planning to start yoga soon
  • Receiving or planning to receive structured psychological therapy during the study or unstable on psychotropic medication
  • Participated in the intervention group of an exercise study during breast cancer treatment
  • Unable to give informed consent or comply with study requirements
  • Unable to attend training sessions for more than 3 weeks during the intervention
  • Have a body mass index (BMI) over 35 kg/m2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Medical Center Utrecht (UMC Utrecht)

Utrecht, Netherlands, 85500 3508 GA

Actively Recruiting

Loading map...

Research Team

E

Evelyn Monninkhof, Dr.

CONTACT

S

Stefanie Veenhuizen, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here